Integrated Biopharma, Inc. (INBP) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Integrated Biopharma, Inc. Company Snapshot

Business Description:

Integrated Biopharma, Inc. operates in the Pharmaceutical preparations sector. Integrated BioPharma, Inc. (INBP) is engaged in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company's customers are located in the United States. The Company continues to do business as Chem International, Inc. with certain of its customers and certain vendors. The Company's nutraceutical business includes InB:Manhattan Drug Company, Inc. (Manhattan Drug), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers. In our complete report available for purchase the company is compared to: Ligand Pharmaceuticals Inc, Dynavax Technologies Corporation and Dusa Pharmaceuticals, Inc..

Integrated Biopharma, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): .04
(Figures in U.S. Dollars)

1 Week	40.0%	13 Weeks	2.9%

4 Weeks	-41.7%	52 Weeks	-82.5%

Integrated Biopharma, Inc. Key Data:

Ticker:	INBP	Country:	UNITED STATES

Exchanges:	OTC	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2011 Sales	25,133,000 (Year Ending Jan 2012).	Employees:	115

Currency:	U.S. Dollars	Market Cap:	733,778

Fiscal Yr Ends:	June	Shares Outstanding:	20,965,074

Share Type:	Common	Closely Held Shares:	12,071,101

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.